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Abstract
Background: The aim of this study was to investigate the role of gene variations of Toll-like receptors (TLR) 2, 3, 
and 4 on genetic susceptibility to periapical pathosis.
Material and Methods: One hundred patients were included in the study and divided into two groups as follows; 
Control Group (n=50) that have root canal treatment and no periapical lesion, Patient Group (n=50) that have root 
canal treatment and periapical lesion. TLR2 Arg753Gln, TLR3 (c.1377C/T) and TLR4 Asp299Gly and Thr399Ile 
polymorphisms were genotyped by using PCR-RFLP. Genotypical analysis of control and patient groups were 
investigated to disclose whether there is any association between periapical lesions and gene variations. 
Results: There are no significant statistical differences between control and patient groups according to TLR 2 
and 4 gene sequence. On the contrary, CC allele detected 74% for TLR 3 in patient group, and this difference was 
found to be statistically significant (p < 0.005). 
Conclusions: According to these results, it can be suggested that patients with Toll-like receptor 3 gene polymor-
phisms could be susceptible to periapical pathosis.
Key words: Toll-like receptors, periapical pathosis, endodontics.
Özan Ü, Ocak Z, Özan F, Oktay EA, Toptaş O, Şahman H, Yikilgan İ, 
Oruçoğlu H, Er K. Association of Toll-like receptors 2, 3 and 4 genes 
polymorphisms with periapical pathosis risk. Med Oral Patol Oral Cir 
Bucal. 2016 Jul 1;21 (4):e408-12.   
 http://www.medicinaoral.com/medoralfree01/v21i4/medoralv21i4p408.pdf
Article Number: 21081          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed
Scopus, Embase and Emcare 
Indice Médico Español
doi:10.4317/medoral.21081
http://dx.doi.org/doi:10.4317/medoral.21081
Med Oral Patol Oral Cir Bucal. 2016 Jul 1;21 (4):e408-12.                                                                                                         Role of gene variations of Toll-like receptors on periapical pathology
e409
Introduction
The persistent microbial infection within the root canal 
system of the affected tooth causes apical periodontitis 
which is an inflammatory disorder of periradicular tis-
sues. Some problems result in persistent apical perio-
dontitis such as inadequate aseptic control, improper 
access to cavity, missed canals, inadequate instrumen-
tation, debridement, and leaking of restorations (1). 
However, it has recently been proposed that genetic pre-
disposition in certain genes can contribute to persistent 
apical periodontitis (2).
The prime cause of periapical diseases is bacteria. Non-
specific inflammatory reactions occur when the bacteria 
or toxins invade the periapical region from an infected 
root canal. Then  the process continues with specific 
inflammatory reactions that include the production of 
antibodies, complement, cytokines and an array of in-
flammatory mediators targeted at limiting the spread of 
infection and protecting the periapical tissues (3). In ad-
dition, a large and diverse community of viruses that 
have yet to be characterized in patients with periodontal 
disease live in the oral cavity (4). The double-stranded 
RNA (dsRNA) is a molecular pattern associated with 
viral infection and recognized by Toll-like receptor 3 
(TLR3) (5).
Host defense in mammals copes with pathogens 
through 2 types of immunity: innate and adaptive im-
munity. Innate immunity functions as a pathogen sen-
sor and contributes to the eradication of pathogens and 
the establishment of adaptive immunity. These func-
tions heavily depend on pathogen recognition receptors 
(PRRs) (6). Among PRRs, a group of transmembrane 
proteins, Toll-like receptors (TLRs), are distinguished 
by their potent immuno adjuvant ability to activate an-
tigen presenting cells (APCs) (7). TLRs are a family of 
receptors involved in the recognition of a wide range 
of microbial molecules, eg. lipopolysaccharide (LPS) 
from gram negative bacteria and peptidoglycan from 
gram positive bacteria, and innate and adaptive immune 
responses against invading  pathogens (8). Binding of 
TLRs causes the production of inflammatory cytokines, 
including TNF-α and IL-12, and enhances the cells’ an-
timicrobial killing mechanisms and antigen-presenting 
capacity. Thirteen distinct TLR members have been 
identified in mammals. The endogenous ligands re-
leased from damaged tissues and necrotic cells, which 
are termed damage-associated molecular patterns 
(DAMPs), can also recognize and activate the TLRs (9). 
Numerous TLRs endogenous ligands have been identi-
fied. Most of them activate TLR2 and TLR4 (10). The 
mRNA released from necrotic cells may activate TLR3. 
TLR2 and TLR4 recognize bacterial cell-wall compo-
nents, such as peptidoglycan (PGN) and LPS, respec-
tively, whereas TLR3 recognizes the viral replicative 
intermediate double-stranded RNA (dsRNA) (8).
The activation of TLRs in the oral cavity might be a key 
event contributing to infectious exacerbations in oral 
cavity inflammatory disease (11). To our knowledge, 
there has been no genetic research into the relationship 
between TLRs 2, 3, and 4 and periapical pathosis. In 
this study, therefore, we aimed to detect whether there 
is a relationship between apical pathosis and the genetic 
variations of TLR2, 3 and 4. 
Material and Methods
- Sample population
Approval from the local ethics committee was obtained 
for the performance of this study. A total of 100 patients 
were included in the study. Patients were divided into 
2 groups: control Group (CG) (n=50, 28 male and 22 
female) that have root canal treatment and no periapical 
lesion; and Patient Group (PG) (n=50, 29 male and 21 
female) that have root canal treatment and periapical le-
sion. TLRs 2, 3, and 4 gene variations were studied with 
peripheral blood samples obtained from patients. Inclu-
sion criteria for patients were: to volunteer, to be an 
adult and to have had a root canal treatment. Exclusion 
criteria were: not to sign the informed consent form, to 
have uncontrolled diseases, to be pregnant, to be under 
chemotherapy and/or radiotherapy, and periodontally 
involved patients.
- Genomic DNA preparation
Two milliliters of whole blood samples was collected 
into ethylenediaminetetraacetic acid- anticoagulated 
tubes by the standard venipuncture method. Genomic 
DNA extraction from peripheral blood leucocytes was 
carried out using the salting-out method as described by 
Miller et al. (12).
- Polymerase chain reaction (PCR) and enzyme digest 
TLR2 Arg753Gln gene polymorphisms were analyzed 
by the method of Karaca et al. (13). The primers for 
TLR2 Arg753Gln were forward 5’-GCCTACTGGGT-
GGAGAACCT-3’ and reverse 5’-GGCCACTCCA-
GGTAGGTCTT-3’. PCR for TLR2 (Arg753Gln) was 
performed in a total volume of  25 µl containing approxi-
mately 100 ng DNA, 2.5 µl of 10X polymerase buffer, 2 
mmol/L MgCl2, 0.2 mmol/L dNTPs, 0.4 µmol/l of each 
primer and 1 U of Taq polymerase (Thermo Scientific, 
Fisher Scientific-USA 300 Industry Drive, Pittsburgh, 
PA, USA) PCR program on T100 thermal cycler (Bio-
Rad Laboratories 4000 Alfred Nobel Drive Hercules, 
CA, USA) thermal cycler was as follows: an initial de-
naturation step at 94 ºC for 4 min, followed by 33 cycles 
of 30 sec at 94 ºC, 30 sec at 56 ºC, 30 sec at 72 ºC, 
and a final extension step of 8 min at 72 ºC. The PCR 
products were digested by restriction endonuclease AciI 
(New England Biolabs,UK 75-77 Knowl Piece Wilbury 
Way Hitchin, UK) at 37 ºC overnight and then analyzed 
by 10% polyacrylamide gel electrophoresis. Bands of 
228, 75 and 40 bp corresponded to TLR2 CC; 268, 228, 
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75, 40 bp bands were designated as heterozygous CG 
individuals; a band of 268,75 bp corresponded to the ho-
mozygous GG genotype.
PCR for TLR3 (c.1377C/T) was carried out in a total reac-
tion volume of 25µLwith 20 pmol each of forward and re-
verse primer, (F) 5’CCAGG CATAAAAAGCAATATG 
and (R) 5’GGACCAAGGCAAAGGAGTTC, genomic 
DNA (200 ng), and  PCR Master Mix (MBI Fermentas, 
Thermo Scientific). PCR conditions were as follows: 
initial denaturation of 95 ºC for 5 min, 35 cycles of 95 
ºC for 45 s, 55 ºC for 45 s, and 72 ºC for 30 s, followed 
by a final extension of 72 ºC for 7 min. All these reac-
tions were carried out in thermal cycler from T100 ther-
mal cycler (Bio-Rad Laboratories 4000 Alfred Nobel 
Drive Hercules). PCR products were digested by res-
triction endonuclease TaqI (Thermo Scientific) at 65 ºC 
overnight and then analyzed by 10% polyacrylamide gel 
electrophoresis. Bands of 274 bp and 63 bp correspon-
ded to TLR3 CC while 337, 274 and 63 bp bands were 
designated as heterozygous CT individuals; a band of 
337 bp corresponded to the homozygous TT genotype.
Determination of the TLR4 gene polymorphisms was 
accomplished with PCR and restriction fragment length 
polymorphism by the method of Lorenz et al. (14).  The 
primers for TLR4 Asp299Gly were forward 5’-GATT-
AGCATACTTAGACTACT ACCTCGA-3’ and reverse 
5’-GATCAACTTCTGAAAAAGCATT CCCACC-3’. 
The primers for TLR4 Thr399Ile were forward 5’-
GGTTGCTGTTCTCAAAGTGATTTTGGGACAA-3’ 
and reverse 5’-CCTGAAGACTGGAGAGTGAGT-
TAAATGCT-3’. Amplification conditions for TLR4 
gene polymorphisms were described above for TLR2 
polymorphisms, except for MgCl2 concentrations (4.0 
mM MgCl2 for Asp299Gly and 3 mM for Thr399Ile). 
The cycling conditions comprised a hot start at 95º 
C for 10 min., followed by 35 amplification cycles at 
95 ºC for 30 s, 62 ºC for 30 s (Asp299Gly) or 60 ºC 
(Thr399Ile) and 72 ºC for 25 s, followed by one elonga-
tion step at 72 ºC for 5 min. The digest reaction was 
set up using 4µL PCR product, appropriate restriction 
enzyme NcoI (TLR4 Asp299Gly) and HinfI (TLR4 
Thr399Ile), 1 µL10 X enzyme buffer (Promega Corpo-
ration 2800 Woods Hollow Road Madison, WI, USA). 
It was incubated overnight at 37 ºC and electrophoresed 
in 10% polyacrylamide gel to identify the TLR4 alleles 
on the basis of the respective allele size. After diges-
tion, the wild-type TLR4 allele sizes of 249 bp for the 
299 residues and 406 bp for the 399 residues will not 
change; fragment sizes for carriers of the polymorphic 
allele will decrease to 23 bp for the 299 residues and 
29 bp for the 399 residues. To confirm our PCR-RFLP 
results, PCR products for all genotypes were sequenced 
on an automated DNA sequencer (ABI 3130xl Genetic 
Analyzer; PE Applied Biosystems GenTech Scientific 
Inc., Arcade, NY, USA). The primer sequences and res-
triction enzymes used for PCR-RFLP methods for de-
tecting each single nucleotide polymorphism (SNP) are 
shown in table 1. 
- Statistical Analysis
Analyses were performed with Epi Info version 3.5.3. 
Hardy-Weinberg equilibrium and the absence of LD 
were evaluated using the allele procedure of Epi Info 
version 3.5.3. All statistical tests were two-sided and a 
nominal p value low of 0.05 was considered statistically 
significant.
Results 
A total of 50 patients with periapical pathosis and 50 age 
and sex-matched healthy controls were enrolled in the 
study. The mean age was 26.6±4.5 years. There were no 
Single Nucleotide 
Polymorphism
          Forward primer Reverse primer Restriction enzyme
TLR2 Arg753Gln
5’-GCCTACTGGGTGGAGAACCT -3’
5’-GGCCACTCCAGGTAGGTCTT-3’.
AciI
TLR3 (c.1377C/T)
5’-CCAGGCATAAAAAGCAATATG-3’
5’-GGACCAAGGCAAAGGAGTTC-3’
TaqI
TLR4 Asp299Gly
5’-GATTAGCATACTTAGACTACT ACCTCGA-3’
5’-GATCAACTTCTGAAAAAGCATT CCCACC-3’.
NcoI
TLR4 Thr399Ile
5’-GGTTGCTGTTCTCAAAGTGATTTTGGGACAA-3’
5’-CCTGAAGACTGGAGAGTGAGTTAAATGCT-3’.
HinfI
Table 1. Primer sequences and restriction enzymes used for PCR-RFLP methods detecting the each single nucleotide polymorphism.
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significant differences between the two groups in terms 
of age and sex (p > 0.05 for both). Genotypic analyses of 
the patients were investigated to disclose whether there 
is any association between periapical lesions and gene 
variations. All of the 100 patients had CC genotype for 
TLR2 Arg753Gln and TLR4 Thr399Ile. Similar to the 
other groups all of the 100 patients had AA genotype 
for TLR4 Asp299Gly (Table 2). In the patient group, we 
detected a TLR3 CC allele in 37 (74%) patients, CT alle-
le in 9 (18%) patients and TT allele in 4 (8%) patients. In 
the control group, however, 19 (38%) subjects have a CC 
allele, 14 (28%) subjects have a CT allele and 17 (34%) 
subjects have a TT allele. There was a statistically sig-
nificant difference between the groups in terms of CC 
allele frequency (p < 0.005). 
Single Nucleotide 
Polymorphism Control Group Patient Group
TLR2 Arg753Gln CC CC
TLR4 Asp299Gly AA AA
TLR4 Thr399Ile CC CC
Table 2. Genotypes of the control and patient groups except TLR 3.
Discussion
Recent years have seen an exponential increase in the 
number of reports claiming links between genetic poly-
morphisms and a variety of medical diseases. Recently, 
endodontic research has contributed to this growth area. 
If we can understand the genetic basis of diseases, ge-
netic tests to assess disease risk and to develop etiology-
based treatments will soon be a reality (15).
The ultimate goals of root canal treatment are the com-
plete healing of the periapical pathosis and the restora-
tion of function. However, failure does occur despite all 
efforts and strict adherence to the principles of endo-
dontic therapy in 14% to 16% of cases (16). Nair (17) 
defined apical periodontitis as a sequel to an endodontic 
infection that includes a dynamic encounter between 
microbial factors and host defenses. Periapical patholo-
gy is a multifactorial disease representing an interaction 
between a microbial challenge and immune response, 
which results in cytokine production and bone resorp-
tion.
There are limited numbers of clinical studies in the li-
terature about the effect of genetic makeup on periapi-
cal diseases. Recently, the authors of this study investi-
gated the expression of TLR2 in refractory periapical 
lesions (3). We found that periapical cysts are likely to 
be sustained by the immune system via reaction to bac-
terial antigens. In the present study, we investigated the 
role of gene variations of TLRs 2, 3 and 4 on genetic 
susceptibility to periapical lesions. In this study, we did 
not find any statistical relationship between patient and 
control groups at the TLR2 and TLR4 genes polymor-
phisms. The reason for this may be different epigenetic 
changes in gene activity that are not caused by changes 
in the DNA sequence. 
TLR2 and TLR4 gene polymorphisms have previously 
been evaluated in some chronic inflammatory diseases 
(18). Ahmad-Nejad et al. (19) detected TLR2 Arg753-
Gln polymorphism in 11.5% of patients with atopic 
dermatitis. This polymorphism has been found to be 
associated with severe-to moderate atopic dermatitis 
together with the higher levels of total serum IgE and 
superantigen-specific IgE than the non-polymorphic 
atopic dermatitis. In addition, TLR2 Arg753Gln poly-
morphism carriers were found to have an increased risk 
for acne vulgaris in Chinese Han patients (20). TLR4 
gene polymorphisms were found to be associated with 
Behcet’s disease, but not TLR2 Arg753Gln polymor-
phism (21).  The reason for these studies’ results may be 
the different ethnic origin and persons that we selected 
for this study.
In this study, we have found the statistical difference 
between control and patient groups at the TLR3 gene 
polymorphisms. The findings of our study suggest that 
patients with TLR 3 gene polymorphisms could have a 
susceptibility to periapical pathosis. There is no esta-
blished link between periapical pathogenesis and TLR3 
gene polymorphisms; however, there is information 
about the links between different disease pathogene-
ses and those polymorphisms. In one of these studies, 
TLR 3 gene polymorphisms have been implicated in 
increased nasopharyngeal carcinoma risk. Lack of as-
sociation of TLR 3 (c.1377C/T) gene polymorphism 
and increased risk for developing breast cancer has also 
been reported recently. 
Several therapeutic agents targeting the TLRs are now 
under pre-clinical and clinical evaluation. However, 
TLRs act as double-edged swords because of their com-
plexity. It is not clear that TLRs are either promoting or 
inhibiting disease progression. Furthermore, therapeutic 
agents targeting the TLRs must be able to antagonize the 
harmful effects resulting without affecting host defense 
functions. Nonetheless, the potential of harnessing and 
directing the innate immune system with drugs targeting 
TLRs for preventing or treating human inflammatory 
and autoimmune diseases as well as cancer appears to 
be promising (22).
Although, this study is the first report to describe a 
genetic marker that might identify people with an in-
creased risk of periapical pathosis before the beginning 
of endodontic treatment, it has some limitations. The 
study subjects enrolled were all of similar ethnicity; 
since both periapical pathosis patients and, controls 
were of Turkish ethnicity, the possibility of popula-
tion admixture was ruled out. The other limitation of 
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this study is that we only focused on genotyped genes. 
Further studies are necessary to confirm our results in 
terms of gene expression and protein analysis of the in-
terested protein by RNA experiments and western blot-
ting in future.
Within the limitations of the present study, it may be 
concluded that patients with TLR 3 gene polymorphisms 
could have a susceptibility to periapical lesions.
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